Atrial Fibrillation: U.S. Physician and Payer Perceptions Regarding New Anticoagulants - On Demand

Based on our U.S. Physician & Payer Forum report entitled Pradaxa, Xarelto, and Eliquis for Atrial Fibrillation: How Have Phase III Data Informed Physician and Payer Perceptions of These New Anticoagulants?, Decision Resources is offering this exclusive webinar.

Date & Time
Recorded live on Tuesday, December 6, 2011
10 a.m. ET, 4 p.m. CET

Click here to view the invite.

To learn how you can access the recorded playback of this event, please fill out the following form and a representitive will contact you:

*First Name:
*Last Name:
Title:
*Company:
Phone:
*Email Address:
Comments:
*Agreement:	I have read and agree to abide by the Decision Resources Terms of Use and Privacy Policy.

*Required

Filter results: